A Phase 2 Interventional Study of Daridorexant to Prevent Delirium After Heart Surgery

Unknown Phase 2 NCT06630390

Study Description

Evaluating the Use of Daridorexant to Prevent Delirium After Heart Surgery

Study Details

Registry ID:: NCT06630390
Conditions:: POSTOPERATIVE DELIRIUM, POSTOPERATIVE COGNITIVE DECLINE
Phase:: Phase 2
Target Enrollment:: 11 participants
Start Date:: November 11, 2024
Age Range:: 60–999 years
Healthy Volunteers:: No

Study Locations (1 site)

University of Rochester Medical Center
Rochester, New YorkUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →